Literature DB >> 18281929

Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.

Ioannis Papanastasiou1, Andrew Tsotinis, Nicolas Kolocouris, S Radhika Prathalingam, John M Kelly.   

Abstract

To develop functionalized adamantanes for treating African trypanosomiasis, we report on the synthesis of new 1-alkyl-2-aminoadamantanes 1a- i, 1-alkyltricyclo[3.3.1.1 (3,7)]decan-2-guanylhydrazones 2a- g, and their congeneric thiosemicarbazones 3a, b. The potency of these compounds against Trypanosoma brucei was compared to that of amantadine and rimantadine and found to be substantially higher. The most active analogues, 1c, 1d, 2c, 2g, and 3b, illustrate the synergistic effect of the lipophilic character of the C1 side chain and the C2 functionality on trypanocidal activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281929      PMCID: PMC2430315          DOI: 10.1021/jm7014292

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.

Authors:  C Burri; S Nkunku; A Merolle; T Smith; J Blum; R Brun
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

2.  Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.

Authors:  Sylvie Bisser; François-Xavier N'Siesi; Veerle Lejon; Pierre-Marie Preux; Simon Van Nieuwenhove; Constantin Miaka Mia Bilenge; Philippe Būscher
Journal:  J Infect Dis       Date:  2006-12-21       Impact factor: 5.226

3.  In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.

Authors:  J M Kelly; G Quack; M M Miles
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Understanding the mechanism of action of the anti-influenza virus drug amantadine.

Authors:  L H Pinto; R A Lamb
Journal:  Trends Microbiol       Date:  1995-07       Impact factor: 17.079

5.  Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.

Authors:  N Kolocouris; A Kolocouris; G B Foscolos; G Fytas; J Neyts; E Padalko; J Balzarini; R Snoeck; G Andrei; E De Clercq
Journal:  J Med Chem       Date:  1996-08-16       Impact factor: 7.446

6.  The novel GABA adamantane derivative (AdGABA): design, synthesis, and activity relationship with gabapentin.

Authors:  Grigoris Zoidis; Ioannis Papanastasiou; Ioannis Dotsikas; Alejandro Sandoval; Raquel Gouvea Dos Santos; Zeta Papadopoulou-Daifoti; Alexander Vamvakides; Nicolas Kolocouris; Ricardo Felix
Journal:  Bioorg Med Chem       Date:  2005-04-15       Impact factor: 3.641

7.  The anti-influenza virus drug rimantadine has trypanocidal activity.

Authors:  J M Kelly; M A Miles; A C Skinner
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4'-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds.

Authors:  R J Sundberg; D J Dahlhausen; G Manikumar; B Mavunkel; A Biswas; V Srinivasan; H A Musallam; W A Reid; A L Ager
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

9.  Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism.

Authors:  K Mizoguchi; H Yokoo; M Yoshida; T Tanaka; M Tanaka
Journal:  Brain Res       Date:  1994-10-31       Impact factor: 3.252

10.  Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.

Authors:  S Van Nieuwenhove; P J Schechter; J Declercq; G Boné; J Burke; A Sjoerdsma
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

View more
  8 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 2.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

Authors:  Eva Torres; María D Duque; Marta López-Querol; Martin C Taylor; Lieve Naesens; Chunlong Ma; Lawrence H Pinto; Francesc X Sureda; John M Kelly; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2011-12-02       Impact factor: 3.641

4.  Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.

Authors:  Linh Tran; Sy Bing Choi; Belal O Al-Najjar; Muhammad Yusuf; Habibah A Wahab; Ly Le
Journal:  Molecules       Date:  2011-12-08       Impact factor: 4.411

5.  Probing the Effect of Halogen Substituents (Br, Cl, and F) on the Non-covalent Interactions in 1-(Adamantan-1-yl)-3-arylthiourea Derivatives: A Theoretical Study.

Authors:  Lamya H Al-Wahaibi; Divya Sri Grandhi; Samar S Tawfik; Nora H Al-Shaalan; Mohammed A Elmorsy; Ali A El-Emam; M Judith Percino; Subbiah Thamotharan
Journal:  ACS Omega       Date:  2021-02-10

6.  Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.

Authors:  María D Duque; Pelayo Camps; Lenuta Profire; Silvia Montaner; Santiago Vázquez; Francesc X Sureda; Jordi Mallol; Marta López-Querol; Lieve Naesens; Erik De Clercq; S Radhika Prathalingam; John M Kelly
Journal:  Bioorg Med Chem       Date:  2009-02-13       Impact factor: 3.641

7.  Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs.

Authors:  Pelayo Camps; María D Duque; Santiago Vázquez; Lieve Naesens; Erik De Clercq; Francesc X Sureda; Marta López-Querol; Antoni Camins; Mercè Pallàs; S Radhika Prathalingam; John M Kelly; Vanessa Romero; Dolores Ivorra; Diego Cortés
Journal:  Bioorg Med Chem       Date:  2008-10-17       Impact factor: 3.641

8.  Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. brucei.

Authors:  Markos-Orestis Georgiadis; Violeta Kourbeli; Ioannis P Papanastasiou; Andrew Tsotinis; Martin C Taylor; John M Kelly
Journal:  RSC Med Chem       Date:  2019-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.